Nebulizer Market Size, Share & Trends Analysis Report By Type (Jet, Mesh, Ultrasonic), By End Use (Hospitals & Clinics, Emergency Centers, Home Healthcare), And Segment Forecasts, 2022 - 2030

Nebulizer Market Growth & Trends

The global nebulizer market size is expected to reach USD 1.77 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.2% from 2022 to 2030. The rising incidence rate of chronic respiratory diseases, increasing demand for home healthcare devices, and rising geriatric population worldwide are the major factors leading to the market growth.

The COVID-19 outbreak has affected millions of people around the globe. Asthma or COPD patients, who were aware of the risk of airborne transmission of COVID-19, were hesitant with regard to the use of inhaled medications, which are considered a potential source of viral transmission and immunosuppression. Though, medical practitioners advised all such patients to continue using their prescribed inhaled medications, including nebulizers. Nebulized albuterol was recommended in some parts of the U.S. as an alternative to albuterol rescue inhalers when pharmacies faced a shortage of albuterol inhalers.

COVID-19 affects many elderly people. According to the American Lung Association (ALA) in 2020, nebulized therapy is a safe and effective way to manage COPD at home for patients during COVID-19. This consequently promotes the demand for nebulizers. According to the Population Reference Bureau report, "Aging in the United States”, the geriatric population in the U.S. is estimated to increase from 48 million in 2016 to 98 million by 2060. Elderly people are susceptible to respiratory diseases such as COPD and sleep apnea. Therefore, the growing geriatric population is expected to expand the patient pool for manufacturers and propel the growth of the market.

Increasing commercial acceptance of mesh nebulizers due to accurate delivery of the drug to the lung and lower residual volumes also aids in market growth. Furthermore, technological advancements such as drug-device combinations are further expected to create newer opportunities in the market. On the other hand, drug loss during nebulization is the major factor restraining the market growth. However, this can also act as an opportunity for the mesh nebulizer manufacturers as the devices are manufactured to deliver accurate drug dosage while reducing drug loss.

Nebulizer Market Report Highlights

• The jet type segment held the largest revenue share of over 65.0% in 2021 owing to the greater penetration and low cost of the devices
• The mesh type segment is expected to register the fastest CAGR of 7.2% over the forecast period due to various benefits including portability, convenience, homecare application, and accurate dosage delivery
• The hospitals and clinics end-use dominated the market in 2021. Hospitals are an integral part of the healthcare industry and are the major revenue source for the entire industry
• The home healthcare end-use segment is expected to witness significant growth in the forecast period as home healthcare devices have been gaining popularity over the recent years
• North America dominated the market in 2021. This can be attributed to an increase in the incidence of respiratory diseases, supportive government policies, favorable reimbursement schemes, a rise in awareness, and increased use of home care products
• Key players are also contributing to the market growth through partnerships, mergers and acquisitions, and the launch of new products. In March 2021, PARI Pharma GmbH revealed the LAMIRA Nebulizer System authorization for the delivery of Insmed's drug product ARIKAYCE in Japan